https://www.selleckchem.com/pr....oducts/hpk1-in-2.htm
These include therapy timed to periods of disease activity, use of patient stratification biomarkers to align therapeutic target with disease endotype, pharmacodynamic biomarkers to achieve personalized dosing and appropriate combination therapies, and efficacy biomarkers for "treat-to-target" strategies. These principles provide a template for application of personalized medicine to complex diseases.Excess nutritional supply to the growing fetus, resulting from maternal diabetes and obesity, is associated with increased risks of feta
Like
Comment
Share
